Benzinga | Nov 24, 2020 04:17PM EST

Global Cord Blood Q2 EPS $0.16 Beats $0.13 Estimate, Sales $42.07M Beat $39.36M Estimate

Global Cord Blood (NYSE:CO) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.13 by 23.08 percent. This is a 14.29 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $42.07 million which beat the analyst consensus estimate of $39.36 million by 6.88 percent. This is a 4.08 percent decrease over sales of $43.85 million the same period last year.